Patents
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
04/2001
04/05/2001WO2000050378A3 Synthesis of nitroalcohol diastereomers
04/05/2001WO2000048986A8 Low odor choline salts
04/04/2001EP1087953A1 Nitrate salts of antihypertensive medicines
04/04/2001EP1087943A1 Therapeutic biaryl derivatives
04/03/2001US6211364 Process for preparing indane-like compounds
04/03/2001US6211245 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
03/2001
03/29/2001WO2001021601A1 Oxazolin-2 compound and method for preparing trimebutine
03/28/2001EP1086072A1 Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof
03/28/2001EP1086065A4 Combinatorial synthesis of multibinding libraries
03/28/2001EP1086065A1 Combinatorial synthesis of multibinding libraries
03/28/2001EP1085894A1 Beta 3-adrenergic receptor agonists
03/28/2001EP1085889A2 Novel therapeutic agents that modulate endothelin receptors
03/28/2001EP1085887A2 Novel angiotensin receptor modulators and their uses
03/28/2001EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
03/28/2001EP1085868A1 H1-histamine receptor antagonists
03/28/2001EP1085847A2 Novel therapeutic agents that modulate estrogen receptors
03/28/2001EP1035772A4 Fungicidal compositions and methods, and compounds and methods for the preparation thereof
03/28/2001CN1063754C Process for preparing N-alkyl polyhydroxyalkyl amines in aqueous/hydroxy solvents
03/28/2001CN1063744C 15-deoxyspergulin analogs, their method of preparation and their use in therapeutics
03/22/2001WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors
03/21/2001EP1084099A1 Process for the preparation of protected 3-amino-1,2-dihydroxypropane acetal and derivatives thereof
03/21/2001EP1083921A1 Novel leukotriene receptor antagonists and their uses
03/21/2001EP1083917A1 Novel analgesic agents
03/21/2001EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors
03/21/2001EP1083889A2 Method for treating neurodegenerative disorders
03/21/2001EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS
03/21/2001CN1063430C Ethanolamine derivatives
03/20/2001US6204413 Process for the preparation of salts of 1-substituted 2,4-diaminobenzenes
03/20/2001US6204287 Treating vision defects
03/20/2001US6203721 For grafting a substituted difluoromethyl group onto a compound containing electrophilic group
03/20/2001US6203580 Oxidative dyeing
03/15/2001WO2001018005A1 Process for the preparation of benzoxazine derivatives and intermediates therefor
03/15/2001WO2001017944A1 Process for producing optically active aminoalcohol
03/15/2001WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/13/2001US6201150 Method of preparing retroviral protease inhibitor intermediates
03/13/2001US6201120 Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines
03/13/2001US6200461 Method for inhibiting polymerization of ethylenically unsaturated hydrocarbons
03/08/2001WO1999063930A8 Novel angiotensin receptor modulators and their uses
03/08/2001DE19942300A1 Verfahren zur Herstellung von Alkanolaminen mit verbesserter Farbqualität A process for the preparation of alkanolamines having improved color quality
03/08/2001DE19937537A1 Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate 2-substituted derivatives Dialkylaminoalkylbiphenyl
03/07/2001EP1081130A1 Process for the preparation of alkanolamines with improved colour quality
03/07/2001EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors
03/07/2001CN1286687A Method for preparation of citalopram
03/07/2001CN1062854C Salmeterol kinafoate with controlled particulate size
03/06/2001US6197828 Derivatives of (+)-venlafaxine and methods of preparing and using the same
03/01/2001WO2001014313A1 Novel amine and quaternary ammonium compounds made from ketones and aldehydes, and compositions containing them
03/01/2001CA2347826A1 Novel amine and quaternary ammonium compounds made from ketones and aldehydes, and compositions containing them
02/2001
02/27/2001US6194461 Nitrone derivatives
02/22/2001WO2001012583A1 Method for the production of adrenaline
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/21/2001EP0835238B1 New cationic and polycationic amphiphiles, reactives containing the same and their use
02/15/2001WO2001010816A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives
02/15/2001WO2001010433A1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
02/15/2001DE19961274C1 New 2,5-diamino-1-(N-aminophenyl)-aminomethyl-benzene derivatives are used in colorants for keratinous fibers e.g. human hair
02/15/2001CA2382759A1 Agent for the remedy of neural damage having a nitrogen-containing compound as the active ingredient
02/14/2001CN1283613A Method for prepn, of arylamino hydroxy anthraquinone
02/14/2001CN1283612A Catalytic hydrogenation process for preparing p-aminophenol from nitrobenzene
02/14/2001CN1283611A Process for converting (t)-pseudo-ephedrin to (-)-ephedrin
02/13/2001US6187956 Method for preparing of L-phenylephrine hydrochloride
02/13/2001US6187821 Such as 2-amino-2-(3-(4-heptylphenyl)propyl)butane-1,4-diol; immunosuppressant; administering to treat or prevent autoimmune diseases and allergies
02/13/2001CA2126794C Decolorization of alkanolamines and alkyleneamines
02/13/2001CA2006114C Low volatility salts
02/08/2001WO2001009082A1 Process for preparing esterquats
02/08/2001WO2001009077A1 N-substituted norephedrine chiral derivatives, their preparation and their use for the synthesis of optically active functionalised compounds by hydrogen transfer
02/08/2001WO2001008685A1 Acyclic and cyclic amine derivatives
02/08/2001WO2001008672A2 Glucamine compounds for treating hepatitis virus infections
02/08/2001WO2000059851A8 Derivatives of venlafaxine and methods of preparing and using the same
02/08/2001DE19936282A1 Verfahren zur Herstellung von Arylaminohydroxyanthrachinonen A process for preparing Arylaminohydroxyanthrachinonen
02/08/2001CA2379993A1 Acyclic and cyclic amine derivatives
02/08/2001CA2362785A1 Glucamine compounds for treating hepatitis virus infections
02/07/2001EP1074586A1 Process for the preparation of arylaminohydroxyanthraquinones
02/07/2001EP1074541A1 Method for manufacturing aminoalcohol
02/07/2001CN1282730A Compounds with particular structure and anticancer activity and its preparing process
02/07/2001CN1061643C Process for leaching ephedrine
02/06/2001US6184236 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative
02/02/2001CA2314639A1 Preparation of arylaminohydroxyanthraquinones
01/2001
01/31/2001EP1071909A1 Two-photon or higher-order absorbing optical materials
01/31/2001EP1071654A1 A process for preparing chiral (s)-2,3-disubstituted-1-propylamine derivatives
01/31/2001CN1282317A Novel P-aminophenol derivatives and use thereof
01/25/2001WO2001005746A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
01/25/2001WO2001005743A1 3-amino-2-benzyl-1-phenyl-propane derivatives
01/25/2001WO2001005741A1 Method for producing amines by homogeneously catalyzed reductive amination of carbonyl compounds
01/25/2001WO2001005224A1 Agrochemical compositions and surfactant compounds
01/25/2001WO2000066587A3 Polyamines and their use in therapy
01/25/2001WO2000055111A3 Bis(1,3-dihydroxy-prop-2-yl)amine and derivatives thereof in the manufacture of polymers
01/25/2001DE19933421A1 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate 2-benzyl-3-dimethylamino-1-phenyl-propanderi- derivatives
01/25/2001CA2379273A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha.
01/25/2001CA2378723A1 3-amino-2-benzyl-1-phenyl-propane derivatives
01/25/2001CA2375947A1 Agrochemical compositions and surfactant compounds
01/24/2001EP1070046A1 Propanolamine derivatives
01/24/2001EP1069894A1 Spisulosine compounds having antitumour activity
01/18/2001WO2001004105A1 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
01/18/2001DE19938709C1 Adrenaline or its addition salt is prepared on industrial scale with asymmetric hydrogenation as the key step and special sequence of successive steps using a rhodium and bidentate phosphine ligand catalyst system
01/18/2001DE19933611A1 Verfahren zur Herstellung von Aminen durch homogen katalysierte reduktive Aminierung von Carbonylverbindungen A process for preparing amines by homogeneously catalysed reductive amination of carbonyl compounds
01/17/2001EP1069123A1 Process for producing benzothiophenecarboxylic acid amide derivatives
01/17/2001EP1069106A2 Dimethyl-(3-aryl-but-3-enyl) amine derivatives with analgesic activity
01/11/2001WO2001002334A1 Novel process for producing bicyclic amino alcohol
01/11/2001WO2000051546A3 Bupropion metabolites and methods of their synthesis and use
01/10/2001EP1066035A2 Substituted aromatic compounds for treatment of antibiotic resistant infections
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 116